GCP
AXDX

GSA Capital Partners’s Accelerate Diagnostics AXDX Stock Holding History

GSA Capital Partners’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-61,840
Closed -$437K – 1476
2022
Q4 		$437K Buy
61,840
+49,770
+412% +$543K 0.05% 689
2022
Q3 		$183K Buy
+12,070
New +$200K 0.02% 1252
2022
Q2 		– Sell
-16,208
Closed -$233K – 1396
2022
Q1 		$233K Buy
16,208
+10,924
+207% +$311K 0.03% 1075
2021
Q4 		$276K Buy
5,284
+2,493
+89% +$139K 0.03% 994
2021
Q3 		$163K Buy
+2,791
New +$182K 0.02% 1274
2021
Q2 		– Sell
-1,377
Closed -$115K – 1314
2021
Q1 		$115K Sell
1,377
-4,919
-78% -$499K 0.02% 990
2020
Q4 		$477K Buy
+6,296
New +$564K 0.08% 450
2020
Q3 		– Sell
-1,551
Closed -$235K – 1239
2020
Q2 		$235K Buy
+1,551
New +$153K 0.13% 268
2018
Q3 		– Sell
-2,200
Closed -$491K – 1621
2018
Q2 		$491K Sell
2,200
-2,540
-54% -$568K 0.02% 1162
2018
Q1 		$1.08M Buy
4,740
+1,980
+72% +$520K 0.06% 601
2017
Q4 		$723K Sell
2,760
-2,760
-50% -$647K 0.04% 758
2017
Q3 		$1.24M Buy
+5,520
New +$1.36M 0.08% 379
2017
Q2 		– Sell
-3,020
Closed -$731K – 1669
2017
Q1 		$731K Sell
3,020
-1,310
-30% -$299K 0.04% 851
2016
Q4 		$898K Buy
4,330
+3,130
+261% +$743K 0.05% 621
2016
Q3 		$327K Sell
1,200
-5,610
-82% -$1.24M 0.02% 1310
2016
Q2 		$980K Sell
6,810
-70
-1% -$9.39K 0.05% 636
2016
Q1 		$989K Buy
6,880
+5,920
+617% +$835K 0.06% 548
2015
Q4 		$206K Buy
+960
New +$175K 0.01% 1640

Other funds holding AXDX

GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return

GSA Capital Partners's AXDX Position: Q1 2023 in Review

GSA Capital Partners sold out of Accelerate Diagnostics (AXDX) in Q1 2023, closing a stake of 61,840 shares — an estimated $437K sold.

GSA Capital Partners first reported a position in AXDX in Q4 2015 and held it in 18 quarters. The position peaked at $1.24M in Q3 2017. 66 funds tracked by Wall St. Rank hold AXDX as of Q1 2023.

  • GSA Capital Partners reported no remaining Accelerate Diagnostics position as of Q1 2023 after selling out during the quarter.
  • GSA Capital Partners sold 61,840 Accelerate Diagnostics shares in Q1 2023, an estimated $437K.
  • GSA Capital Partners first reported a position in Accelerate Diagnostics in Q4 2015 and held it in 18 quarters.
  • GSA Capital Partners's Accelerate Diagnostics position peaked at $1.24M in Q3 2017.
  • 66 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2023.

Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.